Mr. Reynolds previously held numerous sales leadership positions during his 24 years at Guidant Corp. and Boston Scientific, and also held sales leadership positions at Eli Lilly.
"We’re very excited to add Pat to our senior management team," said Jay Ethridge, CEO of IPG, in the press release. "He has a wealth of experience in developing and building a technical and clinically focused sales and service organization in the implantable device market, which will bring great value to all of IPG’s stakeholders."
Read the press release about Pat Reynolds.
Learn more about Implantable Provider Group.
